Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	hemoglobin beta binding	HBB HBD	1.11e-05	2	67	2	GO:0031722
GeneOntologyMolecularFunction	hemoglobin alpha binding	HBB HBD	1.10e-04	5	67	2	GO:0031721
GeneOntologyMolecularFunction	haptoglobin binding	HBB HBD	4.91e-04	10	67	2	GO:0031720
GeneOntologyMolecularFunction	hemoglobin binding	HBB HBD	5.98e-04	11	67	2	GO:0030492
GeneOntologyCellularComponent	DNA-dependent protein kinase complex	PRKDC XRCC6	1.01e-04	5	67	2	GO:0070418
GeneOntologyCellularComponent	DNA-dependent protein kinase-DNA ligase 4 complex	PRKDC XRCC6	2.10e-04	7	67	2	GO:0005958
GeneOntologyCellularComponent	nonhomologous end joining complex	PRKDC XRCC6	3.59e-04	9	67	2	GO:0070419
GeneOntologyCellularComponent	haptoglobin-hemoglobin complex	HBB HBD	6.54e-04	12	67	2	GO:0031838
GeneOntologyCellularComponent	hemoglobin complex	HBB HBD	6.54e-04	12	67	2	GO:0005833
Domain	-	RASA4 RASA4B	3.79e-05	3	67	2	4.10.1130.10
Domain	FATC	MTOR PRKDC	1.26e-04	5	67	2	PF02260
Domain	Haemoglobin_b	HBB HBD	1.26e-04	5	67	2	IPR002337
Domain	FAT	MTOR PRKDC	1.88e-04	6	67	2	PS51189
Domain	FATC	MTOR PRKDC	1.88e-04	6	67	2	PS51190
Domain	FAT	MTOR PRKDC	1.88e-04	6	67	2	PF02259
Domain	PIK-rel_kinase_FAT	MTOR PRKDC	1.88e-04	6	67	2	IPR003151
Domain	FATC_dom	MTOR PRKDC	1.88e-04	6	67	2	IPR003152
Domain	PIK_FAT	MTOR PRKDC	1.88e-04	6	67	2	IPR014009
Domain	FATC	MTOR PRKDC	1.88e-04	6	67	2	SM01343
Domain	ZF_CCHHC	L3MBTL1 L3MBTL3	2.63e-04	7	67	2	PS51802
Domain	BTK	RASA4 RASA4B	4.49e-04	9	67	2	SM00107
Domain	MBT	L3MBTL1 L3MBTL3	4.49e-04	9	67	2	SM00561
Domain	Znf_Btk_motif	RASA4 RASA4B	4.49e-04	9	67	2	IPR001562
Domain	MBT	L3MBTL1 L3MBTL3	4.49e-04	9	67	2	PS51079
Domain	BTK	RASA4 RASA4B	4.49e-04	9	67	2	PF00779
Domain	ZF_BTK	RASA4 RASA4B	4.49e-04	9	67	2	PS51113
Domain	MBT	L3MBTL1 L3MBTL3	5.60e-04	10	67	2	PF02820
Domain	-	TEX13C EWSR1	5.60e-04	10	67	2	4.10.1060.10
Domain	Mbt	L3MBTL1 L3MBTL3	5.60e-04	10	67	2	IPR004092
Domain	TGc	KY TGM6	6.83e-04	11	67	2	SM00460
Domain	Transglut_core	KY TGM6	6.83e-04	11	67	2	PF01841
Domain	Transglutaminase-like	KY TGM6	6.83e-04	11	67	2	IPR002931
Domain	Globin	HBB HBD	8.18e-04	12	67	2	IPR000971
Domain	Globin	HBB HBD	8.18e-04	12	67	2	PF00042
Domain	GLOBIN	HBB HBD	8.18e-04	12	67	2	PS01033
Domain	-	HBB HBD	9.64e-04	13	67	2	1.10.490.10
Domain	Globin/Proto	HBB HBD	9.64e-04	13	67	2	IPR012292
Domain	RasGAP	RASA4 RASA4B	1.12e-03	14	67	2	SM00323
Domain	RasGAP_CS	RASA4 RASA4B	1.12e-03	14	67	2	IPR023152
Domain	HEAT	MTOR PRKDC ECPAS	1.18e-03	58	67	3	IPR000357
Domain	RasGAP	RASA4 RASA4B	1.29e-03	15	67	2	PF00616
Domain	RAS_GTPASE_ACTIV_1	RASA4 RASA4B	1.29e-03	15	67	2	PS00509
Domain	RAS_GTPASE_ACTIV_2	RASA4 RASA4B	1.29e-03	15	67	2	PS50018
Domain	PI3/4_kinase_CS	MTOR PRKDC	1.29e-03	15	67	2	IPR018936
Domain	Globin-like	HBB HBD	1.47e-03	16	67	2	IPR009050
Domain	-	RASA4 RASA4B	1.47e-03	16	67	2	1.10.506.10
Domain	-	MTOR PRKDC	1.47e-03	16	67	2	1.10.1070.11
Domain	PI3Kc	MTOR PRKDC	1.47e-03	16	67	2	SM00146
Domain	PDZ	AHNAK FRMPD2 SYNPO2L AHNAK2	1.65e-03	141	67	4	PF00595
Domain	PI3/4_kinase_cat_dom	MTOR PRKDC	1.87e-03	18	67	2	IPR000403
Domain	PI3_PI4_kinase	MTOR PRKDC	1.87e-03	18	67	2	PF00454
Domain	RasGAP_dom	RASA4 RASA4B	1.87e-03	18	67	2	IPR001936
Domain	PI3_4_KINASE_3	MTOR PRKDC	1.87e-03	18	67	2	PS50290
Domain	PI3_4_KINASE_1	MTOR PRKDC	1.87e-03	18	67	2	PS00915
Domain	PI3_4_KINASE_2	MTOR PRKDC	1.87e-03	18	67	2	PS00916
Domain	PDZ	AHNAK FRMPD2 SYNPO2L AHNAK2	1.97e-03	148	67	4	SM00228
Domain	HEAT_REPEAT	MTOR PRKDC ECPAS	2.03e-03	70	67	3	PS50077
Domain	-	AHNAK FRMPD2 SYNPO2L AHNAK2	2.07e-03	150	67	4	2.30.42.10
Domain	PDZ	AHNAK FRMPD2 SYNPO2L AHNAK2	2.12e-03	151	67	4	PS50106
Domain	PDZ	AHNAK FRMPD2 SYNPO2L AHNAK2	2.17e-03	152	67	4	IPR001478
Domain	JmjC	PHF2 KDM3B	3.33e-03	24	67	2	PF02373
Domain	ZF_RANBP2_1	TEX13C EWSR1	3.33e-03	24	67	2	PS01358
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	PHF2 AHNAK EWSR1 FAM98A PRKDC HBB HBD L3MBTL3 PLRG1 XRCC6 ISY1 ATP5F1B	3.01e-07	954	68	12	36373674
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	ACADVL AHNAK ZNF805 EWSR1 PRKDC ECPAS HBB XRCC6 ATP5F1B AHNAK2 EPG5	4.51e-07	807	68	11	30575818
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	PHF2 ACADVL AHNAK KDM3B MAK16 PRKCB EWSR1 FAM98A PRKDC HBB PLRG1 XRCC6 ATP5F1B	1.41e-06	1318	68	13	30463901
Pubmed	An E3 ubiquitin ligase, Really Interesting New Gene (RING) Finger 41, is a candidate gene for anxiety-like behavior and beta-carboline-induced seizures.	KDM3B HBB HBD	2.02e-06	13	68	3	18986647
Pubmed	A negative regulatory sequence near the mouse beta-maj globin gene associated with a region of potential Z-DNA.	HBB HBD	3.77e-06	2	68	2	6086313
Pubmed	Thrombocytopenia and erythrocytosis in mice with a mutation in the gene encoding the hemoglobin β minor chain.	HBB HBD	3.77e-06	2	68	2	22203977
Pubmed	Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.	MTOR PRKDC	3.77e-06	2	68	2	27235137
Pubmed	A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia.	HBB HBD	3.77e-06	2	68	2	16631345
Pubmed	DNA-PKcs and Ku70 are predictive markers for poor prognosis of patients with gall bladder malignancies.	PRKDC XRCC6	3.77e-06	2	68	2	25046228
Pubmed	Perturbations in lipid metabolism and gut microbiota composition precede cardiac dysfunction in a mouse model of thalassemia.	HBB HBD	3.77e-06	2	68	2	37902616
Pubmed	Cloning specific segments of the mammalian genome: bacteriophage lambda containing mouse globin and surrounding gene sequences.	HBB HBD	3.77e-06	2	68	2	270684
Pubmed	Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.	HBB HBD	3.77e-06	2	68	2	21099112
Pubmed	A large upstream region is not necessary for gene expression or hypersensitive site formation at the mouse beta -globin locus.	HBB HBD	3.77e-06	2	68	2	11121056
Pubmed	Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced nonalcoholic fatty liver.	MTOR ESRRA	3.77e-06	2	68	2	23562079
Pubmed	Pleiotropic control of glucose and hormone responses by PRL1, a nuclear WD protein, in Arabidopsis.	PRKCB PLRG1	3.77e-06	2	68	2	9765207
Pubmed	A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.	HBB HBD	3.77e-06	2	68	2	12480689
Pubmed	CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.	RASA4 RASA4B	3.77e-06	2	68	2	11448776
Pubmed	Comparison of total sequence of a cloned rabbit beta-globin gene and its flanking regions with a homologous mouse sequence.	HBB HBD	3.77e-06	2	68	2	482942
Pubmed	Protein kinase C-β mediates neuronal activation of Na(+)/H(+) exchanger-1 during glutamate excitotoxicity.	SLC9A1 PRKCB	3.77e-06	2	68	2	24378530
Pubmed	Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity.	HBB HBD	3.77e-06	2	68	2	11830454
Pubmed	Second generation knockout sickle mice: the effect of HbF.	HBB HBD	3.77e-06	2	68	2	11154217
Pubmed	Decreased hepcidin mRNA expression in thalassemic mice.	HBB HBD	3.77e-06	2	68	2	14675418
Pubmed	Nucleotide sequences of the mouse globin beta gene cDNAs in a wild derived new haplotype Hbb(w1).	HBB HBD	3.77e-06	2	68	2	10441738
Pubmed	Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche.	HBB HBD	3.77e-06	2	68	2	32344432
Pubmed	Responses of primary osteoblasts and osteoclasts from hemizygous β-globin knockout thalassemic mice with elevated plasma glucose to 1,25-dihydroxyvitamin D3.	HBB HBD	3.77e-06	2	68	2	31562377
Pubmed	The complete nucleotide sequence of a beta-globin-like structure, beta h2, from the [Hbb]d mouse BALB/c.	HBB HBD	3.77e-06	2	68	2	6736028
Pubmed	Running exercise alleviates trabecular bone loss and osteopenia in hemizygous β-globin knockout thalassemic mice.	HBB HBD	3.77e-06	2	68	2	24780610
Pubmed	Effects of human gamma-globin in murine beta-thalassaemia.	HBB HBD	3.77e-06	2	68	2	16803575
Pubmed	First report on the co-inheritance of beta-globin IVS-I-5 (G-->C) thalassemia with delta globin CD12 {Asn-->Lys (AAT-->AAA)}HbA₂-NYU in Iran.	HBB HBD	3.77e-06	2	68	2	21194254
Pubmed	DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer.	MTOR PRKDC	3.77e-06	2	68	2	32209447
Pubmed	The adult beta-globin genes of the "single" type mouse C57BL.	HBB HBD	3.77e-06	2	68	2	7237554
Pubmed	Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of beta-thalassemia.	HBB HBD	3.77e-06	2	68	2	18603555
Pubmed	Comparison of cloned rabbit and mouse beta-globin genes showing strong evolutionary divergence of two homologous pairs of introns.	HBB HBD	3.77e-06	2	68	2	264241
Pubmed	Lack of neighborhood effects from a transcriptionally active phosphoglycerate kinase-neo cassette located between the murine beta-major and beta-minor globin genes.	HBB HBD	3.77e-06	2	68	2	11418464
Pubmed	Hepcidin and 1,25(OH)2D3 effectively restore Ca2+ transport in β-thalassemic mice: reciprocal phenomenon of Fe2+ and Ca2+ absorption.	HBB HBD	3.77e-06	2	68	2	27245334
Pubmed	Co-inheritance of alpha- and beta-thalassaemia in mice ameliorates thalassaemic phenotype.	HBB HBD	3.77e-06	2	68	2	17493845
Pubmed	An altered REDOX environment, assisted by over-expression of fetal hemoglobins, protects from inflammatory colitis and reduces inflammatory cytokine expression.	HBB HBD	3.77e-06	2	68	2	28641125
Pubmed	Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapy.	PRKDC XRCC6	3.77e-06	2	68	2	29397516
Pubmed	A mouse model for beta 0-thalassemia.	HBB HBD	3.77e-06	2	68	2	8524813
Pubmed	Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S.	HBB HBD	3.77e-06	2	68	2	21304105
Pubmed	Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous B1/B2 globin gene deletion) mice.	HBB HBD	3.77e-06	2	68	2	25616571
Pubmed	In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia.	HBB HBD	3.77e-06	2	68	2	30422819
Pubmed	β-Globin cis-elements determine differential nuclear targeting through epigenetic modifications.	HBB HBD	3.77e-06	2	68	2	24297746
Pubmed	Cloning and amplification of alpha and beta mouse globin gene sequences synthesised in vitro.	HBB HBD	3.77e-06	2	68	2	338418
Pubmed	Nephrectomy Does not Exacerbate Cancellous Bone loss in Thalassemic Mice.	HBB HBD	3.77e-06	2	68	2	32385316
Pubmed	The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells.	AHNAK AHNAK2	3.77e-06	2	68	2	15007166
Pubmed	The evolution and sequence comparison of two recently diverged mouse chromosomal beta--globin genes.	HBB HBD	3.77e-06	2	68	2	519759
Pubmed	Murine cell line SX9 bearing a mutation in the dna-pkcs gene exhibits aberrant V(D)J recombination not only in the coding joint but also in the signal joint.	PRKDC XRCC6	3.77e-06	2	68	2	9582343
Pubmed	Intragenic motifs regulate the transcriptional complexity of Pkhd1/PKHD1.	PKHD1 PRKDC	3.77e-06	2	68	2	24984783
Pubmed	AHNAK1 and AHNAK2 are costameric proteins: AHNAK1 affects transverse skeletal muscle fiber stiffness.	AHNAK AHNAK2	3.77e-06	2	68	2	20833135
Pubmed	Neutralizing the function of a β-globin-associated cis-regulatory DNA element using an artificial zinc finger DNA-binding domain.	HBB HBD	3.77e-06	2	68	2	23074246
Pubmed	Humanized beta-thalassemia mouse model containing the common IVSI-110 splicing mutation.	HBB HBD	3.77e-06	2	68	2	16421096
Pubmed	High phosphate intake induces bone loss in nephrectomized thalassemic mice.	HBB HBD	3.77e-06	2	68	2	35622784
Pubmed	A humanized mouse model for a common beta0-thalassemia mutation.	HBB HBD	3.77e-06	2	68	2	15780748
Pubmed	Deletion and replacement of the mouse adult beta-globin genes by a "plug and socket" repeated targeting strategy.	HBB HBD	3.77e-06	2	68	2	7935410
Pubmed	Evolution of the mouse beta-globin genes: a recent gene conversion in the Hbbs haplotype.	HBB HBD	3.77e-06	2	68	2	3870864
Pubmed	Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene.	HBB HBD	3.77e-06	2	68	2	11877258
Pubmed	Hepatitis C virus-core protein facilitates the degradation of Ku70 and reduces DNA-PK activity in hepatocytes.	PRKDC XRCC6	3.77e-06	2	68	2	19467273
Pubmed	Molecular characterization of (deltabeta)(0)/beta(0)-thalassemia and (deltabeta)(0)-thalassemia/hemoglobin E in Thai patients.	HBB HBD	3.77e-06	2	68	2	11860449
Pubmed	Tracking of mouse cell lineage using microinjected DNA sequences: analyses using genomic Southern blotting and tissue-section in situ hybridizations.	HBB HBD	3.77e-06	2	68	2	3428512
Pubmed	The molecular characterization of an A:T to G:C transition in the Hbb-b1 gene of the murine homologue of hemoglobin Rainier.	HBB HBD	3.77e-06	2	68	2	1820025
Pubmed	Super-resolution imaging reveals three-dimensional folding dynamics of the β-globin locus upon gene activation.	HBB HBD	3.77e-06	2	68	2	22767512
Pubmed	Transgene copy number-dependent rescue of murine beta-globin knockout mice carrying a 183 kb human beta-globin BAC genomic fragment.	HBB HBD	3.77e-06	2	68	2	15820143
Pubmed	The beta-delta crossover leading to the beta delta hybrid gene of hemoglobin P-Nilotic is located within 54 base-pairs of the 5' end of exon 2 or between codons 31 and 50.	HBB HBD	3.77e-06	2	68	2	3620470
Pubmed	An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis.	RASA4 RASA4B	3.77e-06	2	68	2	16041389
Pubmed	Growth retardation and leaky SCID phenotype of Ku70-deficient mice.	PRKDC XRCC6	3.77e-06	2	68	2	9390689
Pubmed	Model mice for Presbyterian hemoglobinopathy (Asn(beta108)-->Lys) confer hemolytic anemia with altered oxygen affinity and instability of Hb.	HBB HBD	3.77e-06	2	68	2	12127975
Pubmed	The sequence of the chromosomal mouse beta-globin major gene: homologies in capping, splicing and poly(A) sites.	HBB HBD	3.77e-06	2	68	2	569555
Pubmed	The chromatin "landscape" of a murine adult β-globin gene is unaffected by deletion of either the gene promoter or a downstream enhancer.	HBB HBD	3.77e-06	2	68	2	24817273
Pubmed	Ligation-mediated amplification of RNA from murine erythroid cells reveals a novel class of beta globin mRNA with an extended 5'-untranslated region.	HBB HBD	3.77e-06	2	68	2	8041612
Pubmed	A 66-base pair insert bridges the deletion responsible for a mouse model of beta-thalassemia.	HBB HBD	3.77e-06	2	68	2	3017971
Pubmed	The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model.	HBB HBD	3.77e-06	2	68	2	33822774
Pubmed	Evaluation of Stem Cell-Derived Red Blood Cells as a Transfusion Product Using a Novel Animal Model.	HBB HBD	3.77e-06	2	68	2	27959920
Pubmed	Intervening sequence of DNA identified in the structural portion of a mouse beta-globin gene.	HBB HBD	3.77e-06	2	68	2	273235
Pubmed	Mouse haemoglobin beta chains. Comparative sequence data on adult major and minor beta chains from two species, Mus musculus and Mus cervicolor.	HBB HBD	3.77e-06	2	68	2	999642
Pubmed	Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia.	HBB HBD	3.77e-06	2	68	2	22427201
Pubmed	Mild-intensity physical activity prevents cardiac and osseous iron deposition without affecting bone mechanical property or porosity in thalassemic mice.	HBB HBD	3.77e-06	2	68	2	35396390
Pubmed	Heparanase Level and Procoagulant Activity Are Increased in Thalassemia and Attenuated by Janus Kinase 2 Inhibition.	HBB HBD	3.77e-06	2	68	2	32745462
Pubmed	Molecular characterization of a novel homozygous deletion in β-globin cluster causing (δβ)0-Thalassemia among Tunisian family.	HBB HBD	3.77e-06	2	68	2	36214153
Pubmed	The isolation and characterization of linked delta- and beta-globin genes from a cloned library of human DNA.	HBB HBD	3.77e-06	2	68	2	728996
Pubmed	Expression of HbC and HbS, but not HbA, results in activation of K-Cl cotransport activity in transgenic mouse red cells.	HBB HBD	3.77e-06	2	68	2	14615383
Pubmed	CNTO 530 increases expression of HbA and HbF in murine models of β-thalassemia and sickle cell anemia.	HBB HBD	3.77e-06	2	68	2	23157711
Pubmed	HbA2-Partinico or delta(A2)Pro-->Thr, a new genetic variation in the delta-globin gene in cis to the beta(+) thal IVS-I-110 G>A, and the heterogeneity of delta-globin alleles in double heterozygotes for beta- and delta-globin gene defects.	HBB HBD	3.77e-06	2	68	2	19609526
Pubmed	Discovery of a new HBB haplotype w2 in a wild-derived house mouse, Mus musculus.	HBB HBD	3.77e-06	2	68	2	18299925
Pubmed	Hemoglobin induction in mouse macrophages.	HBB HBD	3.77e-06	2	68	2	10359765
Pubmed	Evolution of duplicated beta-globin genes and the structural basis of hemoglobin isoform differentiation in Mus.	HBB HBD	3.77e-06	2	68	2	19675095
Pubmed	Transposition of a long member of the L1 major interspersed DNA family into the mouse beta globin gene locus.	HBB HBD	3.77e-06	2	68	2	2991851
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	GGH ACADVL AHNAK EWSR1 FAM98A PRKDC HBB HBD XRCC6 ATP5F1B	5.48e-06	844	68	10	25963833
Pubmed	Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.	PRKDC XRCC6	1.13e-05	3	68	2	11406603
Pubmed	Abnormal DNA-PKcs and Ku 70/80 expression may promote malignant pathological processes in gastric carcinoma.	PRKDC XRCC6	1.13e-05	3	68	2	24187467
Pubmed	A mouse model of β-thalassemia shows a liver-specific down-regulation of Abcc6 expression.	HBB HBD	1.13e-05	3	68	2	21281810
Pubmed	An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis.	HBB HBD	1.13e-05	3	68	2	17607360
Pubmed	Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.	HBB HBD	1.13e-05	3	68	2	28151426
Pubmed	Mapping of protein-protein interactions within the DNA-dependent protein kinase complex.	PRKDC XRCC6	1.13e-05	3	68	2	10446239
Pubmed	Oxygen affinity of hemoglobin regulates O2 consumption, metabolism, and physical activity.	HBB HBD	1.13e-05	3	68	2	12458204
Pubmed	Deletion of individual Ku subunits in mice causes an NHEJ-independent phenotype potentially by altering apurinic/apyrimidinic site repair.	PRKDC XRCC6	1.13e-05	3	68	2	24466051
Pubmed	The DNA-PK catalytic subunit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation.	PRKDC XRCC6	1.13e-05	3	68	2	19664609
Pubmed	In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse.	HBB HBD	1.13e-05	3	68	2	10079113
Pubmed	Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling.	HBB HBD	1.13e-05	3	68	2	22461476
Pubmed	Secondary structure of mouse and rabbit alpha- and beta-globin mRNAs: differential accessibility of alpha and beta initiator AUG codons towards nucleases.	HBB HBD	1.13e-05	3	68	2	7357610
Cytoband	Ensembl 112 genes in cytogenetic band chr13q14	ATP7B ALG11 FNDC3A NUFIP1	4.86e-04	244	68	4	chr13q14
Cytoband	2q24.1	DAPL1 GALNT5	7.41e-04	27	68	2	2q24.1
Cytoband	13q14.2	ALG11 FNDC3A	7.41e-04	27	68	2	13q14.2
Cytoband	10q22.2	ZSWIM8 SYNPO2L	1.71e-03	41	68	2	10q22.2
GeneFamily	Sterile alpha motif domain containing\|MBT domain containing	L3MBTL1 L3MBTL3	2.06e-04	9	44	2	1263
GeneFamily	Hemoglobin subunits	HBB HBD	2.57e-04	10	44	2	940
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA4 RASA4B	2.57e-04	10	44	2	830
GeneFamily	PDZ domain containing	AHNAK FRMPD2 SYNPO2L AHNAK2	5.02e-04	152	44	4	1220
GeneFamily	PHD finger proteins\|Lysine demethylases	PHF2 KDM3B	1.54e-03	24	44	2	485
ToppCell	droplet-Marrow-BM-1m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK VCAN CTSA F10	6.52e-06	169	69	5	8066b4c02c97d00034802cff2b39799ef44cc904
ToppCell	droplet-Marrow-nan-18m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK VCAN CTSA F10	7.72e-06	175	69	5	510c46bfd250ef83fcad8f6b01efbcca9d71a9a2
ToppCell	droplet-Marrow-nan-24m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK VCAN CTSA F10	7.94e-06	176	69	5	eddac2ba68d234e3f56f4ca0e11c19bc0e95b6e1
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK VCAN CTSA F10	7.94e-06	176	69	5	1bf8fed48bd224f09efe90a38233b1f01d7311fe
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_activated\|COVID-19_Mild / Disease group, lineage and cell class	AHNAK PRSS23 ECPAS ATP5F1B MYBL1	8.16e-06	177	69	5	6978a22fef40c8b455342373abe7593f5ede0fa4
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AHNAK VCAN ECPAS RIC1 ATP5F1B	1.18e-05	191	69	5	c9f3bdb5c0a90268cab24a0fe4c3a8290fcedeb8
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AHNAK VCAN ECPAS RIC1 ATP5F1B	1.21e-05	192	69	5	b86476037ddf8904c1d8a6b3763af7242c031cf3
ToppCell	10x5'-bone_marrow\|World / Manually curated celltypes from each tissue	ITPRIP PRSS23 HBB HBD ATP5F1B	1.21e-05	192	69	5	34777fa7dc001b6d601376a23aab995e2cec043c
ToppCell	343B-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MTFR1 ZBTB21 HBB CTSA L3MBTL3	1.21e-05	192	69	5	445985fe1bcd33e4f0a1704b27988fbfc9334538
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK VCAN CTSA F10	1.24e-05	193	69	5	5a201ee6f132357c9aacfbad3ae56ed9854c25fd
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	AHNAK VCAN ECPAS RIC1 ATP5F1B	1.34e-05	196	69	5	15397ec27167bb2fb6fec120b68bf38fc71b2670
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|COVID-19_Mild / Disease condition and Cell class	AHNAK VCAN ECPAS RIC1 ATP5F1B	1.34e-05	196	69	5	f245e929a286cb097130572e1027b4f01be8b04d
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AHNAK CCDC190 PRSS23 HBB AHNAK2	1.37e-05	197	69	5	5c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1 AHNAK VCAN PKHD1 CHD9	1.44e-05	199	69	5	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	remission-multiplets\|World / disease stage, cell group and cell class	HBD NLGN2 HBB MYBL1	7.01e-05	142	69	4	286d01b4f95e9c0b38b91958f925f3797dffd596
ToppCell	facs-Marrow-T-cells-24m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK VCAN CTSA F10	9.13e-05	152	69	4	d279592c501fca9cb474ad916fea32282e6969cb
ToppCell	facs-Marrow-T-cells-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK VCAN CTSA F10	9.13e-05	152	69	4	3b59143b2b4ee24eb6378f87ff568124193256e9
ToppCell	11.5-Distal-RBC\|Distal / Age, Tissue, Lineage and Cell class	DNAJB13 HBD GALNT5 HBB	1.19e-04	163	69	4	e9d814952d824539ff1dea119e4fca14a8c335a8
ToppCell	11.5-Distal-RBC-RBC\|Distal / Age, Tissue, Lineage and Cell class	DNAJB13 HBD GALNT5 HBB	1.19e-04	163	69	4	31b60e065bac4ad380247964e7574f210106ebae
ToppCell	facs-Marrow-T_cells-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK VCAN CTSA F10	1.19e-04	163	69	4	30cd95d4f37bd54c1fde54960cb005db58bdd30c
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	AHNAK PRKCB CHD9 HBB	1.19e-04	163	69	4	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK VCAN CTSA F10	1.19e-04	163	69	4	ab934cb986495adfc8dbe5a276577f2a8fb6ee03
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_1\|COVID-19_Mild / Disease condition and Cell class	VCAN ECPAS RIC1 ATP5F1B	1.25e-04	165	69	4	ef709c5d3231c65d351316e1e31b9c9eba721628
ToppCell	ICU-NoSEP-Lymphocyte-T_NK-CD4_CTL\|ICU-NoSEP / Disease, Lineage and Cell Type	DNAJB13 CCDC190 PRSS23 MYBL1	1.37e-04	169	69	4	cbda36f32bd78322dcfe303a44413415d08e5ea3
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythroid_lineage_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DAPL1 HBD GALNT5 HBB	1.40e-04	170	69	4	288014dedda8babc51fe08e48a55e68d83e1b1d2
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK VCAN CTSA F10	1.50e-04	173	69	4	807183fc23478da9451906dacd88de4e73112e0d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	AHNAK PRKCB CHD9 HBB	1.50e-04	173	69	4	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK VCAN CTSA F10	1.50e-04	173	69	4	2e683ec555dc0036875e0f5674dcc5e93ead205d
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell\|TCGA-Thryoid / Sample_Type by Project: Shred V9	VCAN CTSA PLRG1 AHNAK2	1.50e-04	173	69	4	2e9dc137f3675eee07f941eb4cfcaf24a83ab0fb
ToppCell	Immune_cells-Monocytes\|Immune_cells / Lineage and Cell class	GGH AHNAK CTSA F10	1.50e-04	173	69	4	3eced40a65453a023a1673658592e7e2a099119b
ToppCell	droplet-Marrow-BM-30m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK VCAN CTSA F10	1.54e-04	174	69	4	118ba2729ecc6aa1bb8548f3cf537b3f9e902ef0
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK VCAN F10	1.57e-04	175	69	4	69b59ec58e64644deb7e07f31ef495ef4a6f6276
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	DAPL1 ANKRD26 MAP3K13 EPG5	1.57e-04	175	69	4	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK VCAN F10	1.57e-04	175	69	4	4f7498b5a0ed52c348a5f94bcd41d830ba7954ea
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AHNAK ECPAS ATP5F1B MYBL1	1.64e-04	177	69	4	d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCell	Healthy-RBC\|World / disease group, cell group and cell class	VCAN HBD GALNT5 HBB	1.64e-04	177	69	4	2ce41e37fa7139c7bd2b464bd86c5601dc501515
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AHNAK ECPAS ATP5F1B MYBL1	1.64e-04	177	69	4	f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	AHNAK ECPAS ATP5F1B MYBL1	1.64e-04	177	69	4	936ab2b180a052387124f68d0c7f41c0b164e748
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AHNAK ECPAS ATP5F1B MYBL1	1.64e-04	177	69	4	d5aeda113afaa2425874394610344570c9078478
ToppCell	droplet-Marrow-nan-21m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK CTSA F10	1.64e-04	177	69	4	b860013f1fd397400a62d66ab521cfc81349ffe2
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK VCAN CTSA F10	1.68e-04	178	69	4	1a578d16008a450c42e73a996247ffecdc2c43f0
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_1\|COVID-19_Severe / Disease condition and Cell class	AHNAK VCAN ECPAS ATP5F1B	1.79e-04	181	69	4	0d07a67e8ee3bca687b378afbc4044434e63556d
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PRKCB ITPRIP PRSS23 MYBL1	1.86e-04	183	69	4	983ca1342ddd365e1f1df32a456394b002b10e41
ToppCell	droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASA4 ECPAS L3MBTL3 NUFIP1	1.86e-04	183	69	4	92ef926e6c1de8477fa4f35d1dae85482d8009de
ToppCell	droplet-Marrow-nan-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASA4 ECPAS L3MBTL3 NUFIP1	1.86e-04	183	69	4	24db9cc717e651586317c6a8e03a3401651273c1
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	AHNAK PRSS23 ATP5F1B MYBL1	1.90e-04	184	69	4	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DAPL1 AHNAK PRSS23 AHNAK2	1.94e-04	185	69	4	e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035
ToppCell	droplet-Marrow-BM-1m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK CTSA F10	2.02e-04	187	69	4	028e7d6e1211e123879d2f353dc32fae1185dd8e
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	ZNF219 ZNF805 NLGN2 L3MBTL3	2.06e-04	188	69	4	8231e635706a296db6b6da1029a33bbc1b52478e
ToppCell	343B-Lymphocytic-ILC-ILC-1\|343B / Donor, Lineage, Cell class and subclass (all cells)	MTFR1 ZBTB21 HBB L3MBTL3	2.06e-04	188	69	4	8f6b45ad82bde65e044d17f0edbc3db90d457915
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ZNF219 VCAN PRKCB PRSS23	2.11e-04	189	69	4	160963355256f7c0f2138da80c90de478f5a9fe8
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	KANSL1 AHNAK RASA4B MYBL1	2.11e-04	189	69	4	0e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	GABRG1 GLDC PKHD1 MYBL1	2.11e-04	189	69	4	c8b8f860aaf6c73863cd79941db6b469c830ef06
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DAPL1 GALNT5 HBB F10	2.15e-04	190	69	4	c90410bb47b8da774dee2a3502f667ce9a7c97d9
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DAPL1 GALNT5 HBB F10	2.15e-04	190	69	4	bc44727e8458a02fae95dc5515b708000d2ee8c4
ToppCell	droplet-Marrow-nan-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK CTSA F10	2.15e-04	190	69	4	95d8dc8488e95158e84a44bb53ea4ab7bf3d44bb
ToppCell	droplet-Marrow-nan-21m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK CTSA F10	2.15e-04	190	69	4	6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3
ToppCell	droplet-Marrow-nan-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH AHNAK CTSA F10	2.15e-04	190	69	4	e2fdbfaf08da3274b6bdda615386aa880040a90a
ToppCell	NS-critical-d_16-33-Epithelial-Secretory-diff\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DAPL1 AHNAK PRSS23 GALNT5	2.24e-04	192	69	4	02b11233b4da2d85b96498b3c6e22e3a31b3d049
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK3 GLDC PKHD1 MYBL1	2.24e-04	192	69	4	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	10x5'-blood\|World / Manually curated celltypes from each tissue	AHNAK VCAN HBB CTSA	2.28e-04	193	69	4	359d4242a7e5e51a3eaf6fe51bc1c653a402b054
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AHNAK VCAN UGT2A3 PKHD1	2.28e-04	193	69	4	0f2167eef8203a5659c8c72e4e77646003d64797
ToppCell	Mesenchymal_cells-Endosteal_fibro.\|Mesenchymal_cells / Lineage and Cell class	AHNAK VCAN PRSS23 AHNAK2	2.33e-04	194	69	4	9a4b5de4d1d8a0aa76fed7b36548ea628f3009cc
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPATA31D1 PRSS23 HBB MYBL1	2.33e-04	194	69	4	a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PRKCB ITPRIP PRSS23 MYBL1	2.33e-04	194	69	4	a8dc3336aa4ef497f6d26cede02ddac425e7c655
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPATA31D1 PRSS23 HBB MYBL1	2.33e-04	194	69	4	0abca32c3547a45cebab0bd69c1f7a0002deaa80
ToppCell	COVID-19_Severe-CD8+_Tem\|COVID-19_Severe / Disease condition and Cell class	AHNAK PRKCB PRSS23 MYBL1	2.37e-04	195	69	4	ff7ae62393e1c858a10592db8e6d9f36b8bae396
ToppCell	Mesenchymal_cells-Endosteal_fibro.\|World / Lineage and Cell class	AHNAK VCAN PRSS23 AHNAK2	2.37e-04	195	69	4	d53974d1866e23c894ffd492ea11d20422919b11
ToppCell	Mild/Remission-Plasmablast\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	GGH ACADVL GLDC FNDC3A	2.42e-04	196	69	4	dcf0a804a79a05454658498d1f87320c7e079219
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GGH DAPL1 PRSS23 AHNAK2	2.47e-04	197	69	4	1d4ccca2ff46fccb3ac052b5148cb7f94231d65a
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACADVL AHNAK VCAN XRCC6	2.47e-04	197	69	4	7293587c875738c1711b8a68d40303a197b01c32
ToppCell	T_cells-CTLs\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	AHNAK PRKCB PRSS23 MYBL1	2.47e-04	197	69	4	28117cf300e169182571fbad0de1681a484a435a
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACADVL AHNAK VCAN XRCC6	2.47e-04	197	69	4	82072bd73634e1ef24dc193e860af7786727313b
ToppCell	(2)_Fibroblasts-(23)_Fibro-4\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	GLDC ECM2 VCAN AHNAK2	2.47e-04	197	69	4	a183919023a4aca90a06be0e5e89c817b38c5574
ToppCell	Monocytes-NUPR1+_Monocytes\|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	ACADVL PRSS23 ATP5F1B AHNAK2	2.47e-04	197	69	4	8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACADVL AHNAK VCAN XRCC6	2.47e-04	197	69	4	b4869013f0523ac73c284e6cdaf64e9ae5213dc5
ToppCell	T_cells-CTLs\|World / Immune cells in Kidney/Urine in Lupus Nephritis	AHNAK PRKCB PRSS23 MYBL1	2.47e-04	197	69	4	2de34e20915a247bee75aa40495e23c20bb23e18
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DAPL1 PRSS23 ATP5F1B AHNAK2	2.52e-04	198	69	4	9718f4c013c347f1b3c785ae232dd2fb6c1fe298
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DAPL1 PRSS23 ATP5F1B AHNAK2	2.52e-04	198	69	4	89ec1e760a193441092571475cc66a3b425f232e
ToppCell	Parenchymal-10x5prime-Hematologic-Erythrocyte-Erythrocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	UGT2A3 HBD HBB MYBL1	2.52e-04	198	69	4	745e966fd52f06485061727cdbd9358b9df7d97d
ToppCell	Parenchymal-10x5prime-Hematologic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	UGT2A3 HBD HBB MYBL1	2.52e-04	198	69	4	24b1138746dd69d1cda419f7070ef5a402d07563
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DAPL1 PRSS23 HBB ATP5F1B	2.52e-04	198	69	4	e3d1c9428ee6f9bcf9cdaf2192d4ebea8cc2a47c
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	ECM2 VCAN NLGN2 PRSS23	2.52e-04	198	69	4	e8c0fbf306fae13e97caa294d7c99a564bd97130
ToppCell	Parenchymal-10x5prime-Hematologic-Erythrocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	UGT2A3 HBD HBB MYBL1	2.52e-04	198	69	4	2a00648d3aa5843d9e924e054c5e973025f86e97
ToppCell	(1)_Osterolineage_cells-(11)_OLC-2\|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	ECM2 AHNAK PRSS23 AHNAK2	2.52e-04	198	69	4	9f9dcf23ffb333105263132d87b90095642294cf
ToppCell	T/NK_cells-CD8+_Naive_T_cell\|T/NK_cells / Lineage and Cell class	AHNAK PRKCB PRSS23 ATP5F1B	2.52e-04	198	69	4	5b78118af2283f2e1ad9c6a6ab448a018bf2f2e0
ToppCell	Sepsis-Leuk-UTI-Others\|Leuk-UTI / Disease, condition lineage and cell class	GGH HROB HBD HBB	2.56e-04	199	69	4	e45fe91f1d1c47a305b0f39d808730723852af00
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AHNAK PRSS23 GALNT5 HBB	2.56e-04	199	69	4	8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85
ToppCell	Sepsis-Leuk-UTI-Others-RBC\|Leuk-UTI / Disease, condition lineage and cell class	GGH HROB HBD HBB	2.56e-04	199	69	4	d9b517199a646c9461c615412ad5b58cf4bed7c8
ToppCell	suprabasal_cell\|World / shred by cell class for turbinate	DAPL1 AHNAK ATP5F1B AHNAK2	2.56e-04	199	69	4	bfab5380ef074d14f0b5ed10851ad5c898eb9a58
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ECM2 AHNAK VCAN PRSS23	2.56e-04	199	69	4	9846d6a31635fde759d55674631c11ab9270a603
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GGH HROB ZGRF1 MYBL1	2.56e-04	199	69	4	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DAPL1 AHNAK PRSS23 AHNAK2	2.56e-04	199	69	4	ba284f984909504221900bca5ea12ada5b2ffd9f
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AHNAK PRSS23 GALNT5 HBB	2.56e-04	199	69	4	0c060ef64341659f4b1247d0264ac12e53a7e12e
ToppCell	(2)_Fibroblasts-(24)_Fibro-5\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	ECM2 AHNAK VCAN AHNAK2	2.56e-04	199	69	4	6c0354f57883330c685a8d9d5d3014ace7eca584
ToppCell	COVID-19-COVID-19_Severe\|COVID-19 / Disease, condition lineage and cell class	GGH HBD HBB CTSA	2.61e-04	200	69	4	3ec89071f002bb66d46146bf4804f91e6f09a36f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AHNAK PRKCB PRSS23 MYBL1	2.61e-04	200	69	4	2bd8c35484fe6b0bc0f9314216786baaa97d1e95
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DAPL1 AHNAK PRSS23 GALNT5	2.61e-04	200	69	4	b68d212159b9d04866ba02ff55c35be247805eec
ToppCell	5'-Airway_Nasal-Epithelial\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DAPL1 AHNAK PRSS23 GALNT5	2.61e-04	200	69	4	358d71329921451c7f5a56f1db0f9989af2299dc
ToppCell	COVID_vent\|World / Disease condition, Lineage, Cell class and subclass	GGH VCAN HBB CTSA	2.61e-04	200	69	4	1d88e5cc4534073f27a7562e1c4b884bd67f09d9
Drug	sebacate	ACADVL MTOR PRKDC TGM6 HBB HBD XRCC6	9.37e-07	181	66	7	CID000005192
Drug	ketononestrol aziridine	ESRRA HBB HBD	6.52e-06	13	66	3	CID000130642
Drug	tricapryl(methyl)ammonium	HBB HBD	8.28e-06	2	66	2	CID011071504
Drug	allyl 2,4,6-tribromophenyl ether	HBB HBD	8.28e-06	2	66	2	CID000076767
Drug	1,3,5-tribromobenzene	HBB HBD	8.28e-06	2	66	2	CID000012279
Drug	AC1L3OJQ	HBB HBD	8.28e-06	2	66	2	CID000119294
Drug	pentabromobenzene	HBB HBD	8.28e-06	2	66	2	CID000011854
Drug	tribromobenzene	HBB HBD	8.28e-06	2	66	2	CID000011842
Drug	Bromkal 73-5 PE	HBB HBD	8.28e-06	2	66	2	CID000118216
Drug	2-(alpha-hydroxybenzyl)-benzimidazole	HBB HBD	8.28e-06	2	66	2	CID000005792
Drug	NSC-334295	HBB HBD	8.28e-06	2	66	2	CID000100107
Drug	Harpagoside [19210-12-9]; Down 200; 8uM; HL60; HT_HG-U133A	SLC9A1 L3MBTL1 ECM2 AHNAK ESRRA ANKRD26	2.23e-05	196	66	6	2935_DN
Drug	Pirenperone [ 75444-65-4]; Down 200; 10.2uM; HL60; HT_HG-U133A	HROB SLC9A1 ZNF219 ATP7B L3MBTL1 ESRRA	2.36e-05	198	66	6	2455_DN
Drug	furyl-dihydropyridine I	HBB HBD	2.48e-05	3	66	2	CID000125806
Drug	Nx-D	HBB HBD	2.48e-05	3	66	2	CID006914638
Drug	mer13	HBB HBD	2.48e-05	3	66	2	CID000107453
Drug	BTBPE	HBB HBD	2.48e-05	3	66	2	CID000037840
Drug	pentabromoethylbenzene	HBB HBD	2.48e-05	3	66	2	CID000006800
Drug	hyoscine-N-butylbromide	HBB HBD MYBL1	2.56e-05	20	66	3	CID000003636
Drug	AC1L2GOW	ITPRIP HBB HBD	2.56e-05	20	66	3	CID000046762
Drug	tamoxifen aziridine	ESRRA HBB HBD	3.44e-05	22	66	3	CID003033894
Drug	Rges Peptide	FNDC3A HBB HBD	3.95e-05	23	66	3	CID000121927
Drug	AC1L4CDO	HBB HBD	4.95e-05	4	66	2	CID000154482
Drug	HPED	HBB HBD	4.95e-05	4	66	2	CID000125856
Drug	PTU-23	HBB HBD	4.95e-05	4	66	2	CID000853760
Drug	IC86621	PRKDC XRCC6	4.95e-05	4	66	2	CID009859309
Drug	AC1L9JVG	HBB HBD	4.95e-05	4	66	2	CID000446603
Drug	4-(2-carboxyvinyl)benzoic acid	HBB HBD	4.95e-05	4	66	2	CID000089196
Drug	1,4-dibromobenzene	HBB HBD	4.95e-05	4	66	2	CID000007804
Drug	1,2,4,5-tetrabromobenzene	HBB HBD	4.95e-05	4	66	2	CID000012486
Drug	H-Ni	PRKDC HBB HBD	7.24e-05	28	66	3	CID000445665
Drug	Bile Acids and Salts	SLC9A1 ATP7B MTOR ATP5F1B	8.22e-05	79	66	4	ctd:D001647
Drug	AC1L8TD7	HBB HBD	8.23e-05	5	66	2	CID000407802
Drug	arildone	HBB HBD	8.23e-05	5	66	2	CID000041782
Drug	1,2,4-tribromobenzene	HBB HBD	8.23e-05	5	66	2	CID000012002
Drug	CaBr2	HBB HBD	8.23e-05	5	66	2	CID000024608
Drug	Hexbbp	HBB HBD	8.23e-05	5	66	2	CID000119134
Drug	AC1LA5IX	FNDC3A HBB HBD	9.87e-05	31	66	3	CID000462147
Drug	AC1ND2OB	MTOR ESRRA VCAN PRKCB HBB HBD	1.19e-04	265	66	6	CID004568637
Drug	2,4-pentanediol	HBB HBD	1.23e-04	6	66	2	CID000012262
Drug	pentabromotoluene	HBB HBD	1.23e-04	6	66	2	CID000006906
Drug	AC1LDLU6	HBB HBD	1.23e-04	6	66	2	CID000620919
Drug	diaspirin	ATP7B HBB HBD	1.31e-04	34	66	3	CID000065042
Drug	Cortisporin	MTOR PRKCB HBB HBD ATP5F1B	1.63e-04	177	66	5	CID000004454
Drug	BP-6	HBB HBD XRCC6	1.68e-04	37	66	3	CID000446948
Drug	triheptanoin	ACADVL MTOR	1.72e-04	7	66	2	CID000069286
Drug	medrylamine	HBB HBD	1.72e-04	7	66	2	CID000010669
Drug	purpald	HBB HBD	1.72e-04	7	66	2	CID002723946
Drug	HBBA	HBB HBD	1.72e-04	7	66	2	CID016072199
Drug	SV-4814	HBB HBD	1.72e-04	7	66	2	CID003010509
Drug	Viroxime	HBB HBD	1.72e-04	7	66	2	CID000051567
Drug	trimesic acid	HBB HBD	1.72e-04	7	66	2	CID000011138
Drug	4-nitrosobiphenyl	HBB HBD	1.72e-04	7	66	2	CID000024971
Drug	bp G	VCAN HBB HBD	1.97e-04	39	66	3	CID000448110
Drug	flourish	KY HBB HBD	1.97e-04	39	66	3	CID000009291
Drug	AC1L2B9U	HBB HBD	2.29e-04	8	66	2	CID000044164
Drug	L 35	HBB HBD	2.29e-04	8	66	2	CID000195347
Drug	AC1Q6S1Y	MTOR ESRRA HBB HBD	2.38e-04	104	66	4	CID000122035
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	SLC9A1 ZNF219 L3MBTL1 ESRRA SYNPO2L	2.56e-04	195	66	5	2663_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; HL60; HT_HG-U133A	HROB SLC9A1 VCAN ANKRD26 FNDC3A	2.69e-04	197	66	5	2205_DN
Drug	Orlistat; Down 200; 10uM; PC3; HT_HG-U133A	L3MBTL1 MTOR ECM2 MAP3K13 HBB	2.75e-04	198	66	5	6388_DN
Drug	dansyl chloride	GGH TGM6 CTSA F10	2.75e-04	108	66	4	CID000011801
Drug	Piperine [94-62-2]; Up 200; 14uM; PC3; HT_HG-U133A	ZNF219 ECM2 AHNAK PRKCB HBB	2.81e-04	199	66	5	4247_UP
Drug	Ringer's lactate	ATP7B HBB HBD	2.83e-04	44	66	3	CID006335487
Drug	4-sulfophenyl isothiocyanate	HBB HBD	2.94e-04	9	66	2	CID000087189
Drug	N,N-diethylphenylacetamide	HBB HBD	2.94e-04	9	66	2	CID000017076
Drug	OP-2507	HBB HBD	2.94e-04	9	66	2	CID006438365
Drug	3H-AMT	HBB HBD	2.94e-04	9	66	2	CID000107680
Drug	AC1L252K	HBB HBD	2.94e-04	9	66	2	CID000015061
Drug	ZSTK474	MTOR PRKDC	2.94e-04	9	66	2	ctd:C510150
Drug	sodium nitrite	KY HBB HBD	3.67e-04	48	66	3	CID004517618
Drug	N-(6-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)benzo(d)thiazol-2-yl)acetamide	MTOR PRKDC	3.67e-04	10	66	2	ctd:C558744
Drug	HS 4	HBB HBD	3.67e-04	10	66	2	CID005493398
Drug	decabromodiphenyl	HBB HBD	3.67e-04	10	66	2	CID000026164
Drug	ferrous succinate	HBB HBD	3.67e-04	10	66	2	CID000159252
Drug	1-butyl-3-methylimidazolium hexafluorophosphate	HBB HBD	3.67e-04	10	66	2	CID002734174
Drug	AC1LADZE	HBB HBD	3.67e-04	10	66	2	CID000486298
Drug	hexabromobenzene	HBB HBD	3.67e-04	10	66	2	CID000006905
Disease	Delta-Beta Thalassemia	HBB HBD	1.39e-05	3	64	2	C0271985
Disease	beta thalassemia (implicated_via_orthology)	HBB HBD	1.39e-05	3	64	2	DOID:12241 (implicated_via_orthology)
Disease	hemoglobin measurement, hemoglobin A2 measurement	HBD HBD	4.61e-05	5	64	2	EFO_0004509, EFO_0005845
Disease	Chloracne	AHNAK HBB HBD	5.07e-05	33	64	3	C0263454
Disease	Adenoid Cystic Carcinoma	KANSL1 VCAN PRKDC MYBL1	6.75e-05	100	64	4	C0010606
Disease	hemoglobin E disease	HBD HBD	6.91e-05	6	64	2	MONDO_0016243
Disease	anemia (biomarker_via_orthology)	HBB HBD	9.66e-05	7	64	2	DOID:2355 (biomarker_via_orthology)
Disease	Metastatic melanoma	MTOR PRKDC MAP3K13	2.23e-04	54	64	3	C0278883
Disease	neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, obsolete_red blood cell distribution width, basophil count, platelet count, eosinophil count	ANKRD26 HBB	2.52e-04	11	64	2	EFO_0004305, EFO_0004308, EFO_0004309, EFO_0004526, EFO_0004528, EFO_0004584, EFO_0004833, EFO_0004842, EFO_0005090, EFO_0005091, EFO_0005192
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	MTOR PKHD1	5.45e-04	16	64	2	DOID:0110861 (implicated_via_orthology)
Disease	brain cancer (implicated_via_orthology)	L3MBTL1 L3MBTL3	1.46e-03	26	64	2	DOID:1319 (implicated_via_orthology)
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	EWSR1 EPG5	1.94e-03	30	64	2	DOID:332 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
TFLDIPLHEKKMTPG	ALG11	286	Q2TAA5
PMIHIYLDKETGKPK	EWSR1	396	Q01844
FHPLLKAVKAGMPIG	EPG5	1006	Q9HCE0
PIKKEESTKHFPKGM	VCAN	2226	P13611
GILIKGGKPLEMAHK	ATP7B	1006	P35670
HGKIKFPTMKVPKFG	AHNAK	301	Q09666
SMPDVDLHLKGPKVK	AHNAK	1196	Q09666
ISIPDVGLHLKGPKM	AHNAK	1451	Q09666
SMPDVDLHLKGPKVK	AHNAK	1856	Q09666
KISMPDVDLHLKGPK	AHNAK	1921	Q09666
MPDVDLHLKGPKVKG	AHNAK	1991	Q09666
KISMPDVDLHLKGPK	AHNAK	2116	Q09666
APKISMPDFDLHLKG	AHNAK	2576	Q09666
MPDFDLHLKGPKVKG	AHNAK	2581	Q09666
GKFKGPKFKIPEMHL	AHNAK	3726	Q09666
ISMPDFDLHLKGPKV	AHNAK	4001	Q09666
KISMPDFDLHLKGPK	AHNAK	4256	Q09666
APKISMPDFDLHLKG	AHNAK	4456	Q09666
MPDFDLHLKGPKVKG	AHNAK	4461	Q09666
LKGPKFKMPDLHLKA	AHNAK	4576	Q09666
KPSHKSLANPGLMKE	ANKRD26	346	Q9UPS8
HPPAVKAGGMRISKK	DAPL1	16	A0PJW8
GHMGKLVPLKETIKG	ATP5F1B	476	P06576
GPLFIHRTKGKGPLM	RASA4	571	O43374
GPLFIHRTKGKGPLM	RASA4B	571	C9J798
KGSPQMKGTPHFKEE	RIC1	111	Q4ADV7
PGSLKIKFRSGKFMP	ITPRIP	331	Q8IWB1
PPHGFQKKMKLEVVD	L3MBTL3	471	Q96JM7
ALSAKHKGKMPLRGP	MAK16	261	Q9BXY0
KVGPKMLDHEGKEVP	ISY1	101	Q9ULR0
PPTMGTHKLQIFAKG	KY	406	Q8NBH2
HDAGLKDPMKSKKQP	CCDC190	126	Q86UF4
ISKSAGAMLKPHAPK	ECPAS	1281	Q5VYK3
LHMPTSKENLKEKGP	PLRG1	56	O43660
FKLGMKLEGIDPQHP	L3MBTL1	306	Q9Y468
KKLSLKHRAPMPGSL	KANSL1	701	Q7Z3B3
KTGLKGIPEHLMGKL	KDM3B	831	Q7LBC6
KGPVPAIHKAGIMSA	HROB	211	Q8N3J3
ICKGLMTKHPGKRLG	PRKCB	571	P05771
KGVPHKSGMQTKRPD	MAP3K13	536	O43283
LFGPHMLKPTGKMKA	MTFR1	311	Q15390
TIKGAGHMVPTDKPL	CTSA	451	P10619
LPKMKAGGHKVLIFS	CHD9	1191	Q3L8U1
IGRMLLNDSKKGPPH	DOCK3	296	Q8IZD9
KLKNKASMTPGLHPG	GABRG1	371	Q8N1C3
PHGDTAKKPIIGILM	GGH	26	Q92820
PMTLHLPGSVVTKKG	FRMPD2	321	Q68DX3
IKEMKPPLRGHGKGA	GALNT5	71	Q7Z7M9
AGPFSHMIKLKTKPL	FNDC3A	936	Q9Y2H6
LPGKKGHCLVKGITM	ECM2	96	O94769
HPKYFKKVPGEGMPL	DNAJB13	266	P59910
MKPGKELKVLSYPAH	ERAP2	131	Q6P179
MGNPKVKAHGKKVLG	HBD	56	P02042
MGNPKVKAHGKKVLG	HBB	56	P68871
MKTRGLPKAKSHAPE	F10	466	P00742
GVKLEGKVPMHKLFL	ESRRA	401	P11474
IRDPGKKPVMLFLHG	NLGN2	171	Q8NFZ4
GGNMALKHTPLKTLP	MYBL1	471	P10243
KDLMGFGTKPRHITP	MTOR	301	P42345
AAPNPHSKGVLMFKK	SYNPO2L	286	Q9H987
HTKEALTKMEPPKKG	PHF2	551	O75151
HVGKPLLKKPMGPAH	FAM98A	186	Q8NCA5
HKRKFMKIGVSPPAK	PRSS23	256	O95084
LHIKGGKLIFMAPGP	PKHD1	1966	P08F94
ITHGPPEKKMGIKAS	ACADVL	291	P49748
GPKVHLPKVEMPSFK	AHNAK2	911	Q8IVF2
GLKGHLPKVEMPSFK	AHNAK2	1076	Q8IVF2
GFKGHLPKVQMPSLK	AHNAK2	1241	Q8IVF2
GLKGHLPKLQMPSFK	AHNAK2	1406	Q8IVF2
GLKGHLPKVQMPSFK	AHNAK2	1571	Q8IVF2
GFKGHLPKVQMPSLK	AHNAK2	1736	Q8IVF2
GLKGHLPKVDMPSFK	AHNAK2	1901	Q8IVF2
GLKGHLPKVEMPSLK	AHNAK2	2066	Q8IVF2
GLKGHLPKLQMPSFK	AHNAK2	2231	Q8IVF2
GLKGHLPKLQMPSFK	AHNAK2	2396	Q8IVF2
GLKGHLPKVQMPSFK	AHNAK2	2561	Q8IVF2
GLKGHLPKLQMPSFK	AHNAK2	2726	Q8IVF2
GLKGHLPKVQMPSFK	AHNAK2	2891	Q8IVF2
GLKGHLPKLQMPSFK	AHNAK2	3056	Q8IVF2
GLKGHLPKLQMPSFK	AHNAK2	3221	Q8IVF2
GLKGHLPKVEMPSFK	AHNAK2	3386	Q8IVF2
GLKGHLPKVEMPSLK	AHNAK2	3551	Q8IVF2
GLKGHLPKVQMPSFK	AHNAK2	3881	Q8IVF2
SLKGHLPKVQMPSFK	AHNAK2	4046	Q8IVF2
GLKGHLPKLQMPSFK	AHNAK2	4376	Q8IVF2
GLKGHLPKVEMPSFK	AHNAK2	4541	Q8IVF2
HEGKGSPLKMPKIKL	AHNAK2	4946	Q8IVF2
TGIFLDLMHLKKPGG	XRCC6	196	P12956
MHPGEKPLGVNKVAK	ZBTB21	691	Q9ULJ3
KILPKAEHFKMPEAG	XAGE2	91	Q96GT9
HAPGMKKIKLDTPEE	NUFIP1	221	Q9UHK0
FKRPHMTAKDLGLPG	TEX37	71	Q96LM6
KMLPKHLQGGKFPPT	SPATA31D1	1561	Q6ZQQ2
HGMKPRKAFPVLGID	SLC9A1	81	P19634
PKEMVPLGDSHSLKK	TEX13C	741	A0A0J9YWL9
TPGHLVKGKGQKTKM	TRBV23-1	26	A0A0A0MS06
MKFLHGKLGNPIVPL	PRKDC	2126	P78527
PGRPKKKHTGMASID	ZSWIM8	1131	A7E2V4
HSQPAKLVMVKKEGP	ZGRF1	1351	Q86YA3
GGLHCKPAKALPKEM	UGT2A3	276	Q6UWM9
AGKFKVLEPPMLGHD	TGM6	496	O95932
QKEKLPGKMSPKHDG	ZNF805	146	Q5CZA5
MKVHASKLGPLRAPG	ZNF219	321	Q9P2Y4
GMGPIGVKKHLAPFL	GLDC	766	P23378